BioMarin Pharmaceutical
BMRN
#1835
Rank
โ‚น1.067 T
Marketcap
โ‚น5,558
Share price
-0.54%
Change (1 day)
-10.32%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: โ‚น1.067 Trillion

As of February 2026 BioMarin Pharmaceutical has a market cap of โ‚น1.067 Trillion. This makes BioMarin Pharmaceutical the world's 1835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.067 T3.27%
2025โ‚น1.033 T-5.46%
2024โ‚น1.093 T-27.67%
2023โ‚น1.512 T-5%
2022โ‚น1.591 T31.83%
2021โ‚น1.207 T3.71%
2020โ‚น1.164 T7.37%
2019โ‚น1.084 T2.17%
2018โ‚น1.061 T6.14%
2017โ‚น999.91 B3.28%
2016โ‚น968.18 B-13.9%
2015โ‚น1.124 T31.64%
2014โ‚น854.21 B37%
2013โ‚น623.52 B83.98%
2012โ‚น338.91 B63.16%
2011โ‚น207.72 B55.59%
2010โ‚น133.50 B51.51%
2009โ‚น88.11 B3.17%
2008โ‚น85.40 B-36.7%
2007โ‚น134.91 B102.63%
2006โ‚น66.58 B84.73%
2005โ‚น36.04 B101.93%
2004โ‚น17.84 B-21.25%
2003โ‚น22.66 B24.66%
2002โ‚น18.18 B-46.49%
2001โ‚น33.98 B103.56%
2000โ‚น16.69 B-6.17%
1999โ‚น17.79 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

โ‚น1.073 Trillion
by Nasdaq info icon info icon
โ‚น1.073 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚น10.619 T 894.62%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚น202.47 B-81.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น14.87 B-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น73.05 B-93.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น408.84 B-61.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น278.12 B-73.95%๐Ÿ‡บ๐Ÿ‡ธ USA